luigi scipione

luigi scipione

Sapienza Università di Roma

H-index: 25

Europe-Italy

About luigi scipione

luigi scipione, With an exceptional h-index of 25 and a recent h-index of 21 (since 2020), a distinguished researcher at Sapienza Università di Roma, specializes in the field of chimica farmaceutica, drug design..

His recent articles reflect a diverse array of research interests and contributions to the field:

A Trojan horse strategy to improve the treatment of Pseudomonas aeruginosa lung infections

Evaluation of the Antifungal and Antiproliferative Properties of the Lichen Roccella tinctoria DC. Extracts and Main Components

Exploring metallophore-antibiotic conjugates as a novel antimicrobial strategy that exploits Pseudomonas aeruginosa zinc dependence

Discovery of quinolinonyl derivatives as anti-HIV-1 inhibitors endowed with an innovative mechanism of action.

Design and synthesis of brain permeable anti-Naegleria fowleri agents targeting CYP51 for primary amoebic meningoencephalitis treatment.

Diketo acid heterocyclic derivatives as new SARS-CoV-2 nsp13 inhibitors blocking viral replication.

Identification of novel aminopyrimidine derivatives as protein kinase inhibitors blocking cell growth.

Pyrimidine-based compounds as new promising protein kinase inhibitors for cancer treatment.

luigi scipione Information

University

Position

Dipartimento chimica e tecnologie del farmaco

Citations(all)

1642

Citations(since 2020)

1027

Cited By

912

hIndex(all)

25

hIndex(since 2020)

21

i10Index(all)

54

i10Index(since 2020)

35

Email

University Profile Page

Sapienza Università di Roma

Google Scholar

View Google Scholar Profile

luigi scipione Skills & Research Interests

chimica farmaceutica

drug design.

Top articles of luigi scipione

Title

Journal

Author(s)

Publication Date

A Trojan horse strategy to improve the treatment of Pseudomonas aeruginosa lung infections

A Battistoni

L Scipione

2024/11/23

Evaluation of the Antifungal and Antiproliferative Properties of the Lichen Roccella tinctoria DC. Extracts and Main Components

Pharmaceutics

Claudio Frezza

Dalia Rosa Fraioli

Francesca Conti

Roberta Maria Nicolosi

Luigi Scipione

...

2024/2/27

Exploring metallophore-antibiotic conjugates as a novel antimicrobial strategy that exploits Pseudomonas aeruginosa zinc dependence

B Palumbo

F Esposito

I Di Trolio

S Ammendola

A Battistoni

...

2024

Discovery of quinolinonyl derivatives as anti-HIV-1 inhibitors endowed with an innovative mechanism of action.

Valentina Noemi Madia

Davide Ialongo

Antonella Messore

Elisa Patacchini

Merve Arpacioglu

...

2023

Design and synthesis of brain permeable anti-Naegleria fowleri agents targeting CYP51 for primary amoebic meningoencephalitis treatment.

VN Madia

D Ialongo

A Messore

E Patacchini

M Arpacioglu

...

2023

Diketo acid heterocyclic derivatives as new SARS-CoV-2 nsp13 inhibitors blocking viral replication.

D Ialongo

VN Madia

A Messore

E Patacchini

M Arpacioglu

...

2023

Identification of novel aminopyrimidine derivatives as protein kinase inhibitors blocking cell growth.

Davide Ialongo

Valentina Noemi Madia

Antonella Messore

Elisa Patacchini

Merve Arpacioglu

...

2023

Pyrimidine-based compounds as new promising protein kinase inhibitors for cancer treatment.

D Ialongo

VN Madia

A Messore

E Patacchini

M Arpacioglu

...

2023

Design and synthesis of tetrahydro-β-carbolines derivatives as PDIA inhibitors.

A Messore

VN Madia

D Ialongo

E Patacchini

M Arpacioglu

...

2023

Aminopyrimidine derivatives as new protein kinase inhibitors endowed with anticancer activity.

D Ialongo

VN Madia

A Messore

E Patacchini

M Arpacioglu

...

2023

New diketo acid derivatives as dual SARS-CoV-2 nsp13 inhibitors active against viral replication.

Davide Ialongo

VALENTINA NOEMI Madia

Antonella Messore

Elisa Patacchini

Merve Arpacioglu

...

2023

New blood-brain-barrier permeable compounds as Naegleria Fowleri CYP51 inhibitors.

M Arpacioglu

VN Madia

D Ialongo

E Patacchini

A Messore

...

2023

Dual HIV-1 integrase catalytic site and integrase-RNA interaction inhibitors.

VN Madia

D Ialongo

A Messore

E Patacchini

M Arpacioglu

...

2023

Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors

Journal of Medicinal Chemistry

Vandna Sharma

Valentina Noemi Madia

Valeria Tudino

Jennifer V Nguyen

Anjan Debnath

...

2023/12/12

Quinolinonyl derivatives as dual inhibitors of the HIV-1 integrase catalytic site and integrase-RNA interactions.

VN Madia

D Ialongo

A Messore

E Patacchini

M Arpacioglu

...

2023

Discovery of new small molecules as anti-SARS-CoV-2 agents inhibiting ACE2-spike binding.

VN Madia

D Ialongo

A Messore

E Patacchini

M Arpacioglu

...

2023

Novel nsp13 inhibitors capable of blocking viral replication of SARS-CoV-2.

M Arpacioglu

VN Madia

A Messore

E Patacchini

D Ialongo

...

2023

Pyrrolyl and Indolyl α-γ-Diketo Acid Derivatives Acting as Selective Inhibitors of Human Carbonic Anhydrases IX and XII

Pharmaceuticals

Davide Ialongo

Antonella Messore

Valentina Noemi Madia

Valeria Tudino

Alessio Nocentini

...

2023/1/27

Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site

Molecules

Valentina Noemi Madia

Davide Ialongo

Elisa Patacchini

Cécile Exertier

Lorenzo Antonelli

...

2023/1/1

Miconazole-like compounds as brain permeable anti-Naegleria Fowleri agents targeting CYP51.

Valentina Noemi Madia

Davide Ialongo

Elisa Patacchini

Antonella Messore

Merve Arpacioglu

...

2023

See List of Professors in luigi scipione University(Sapienza Università di Roma)

Co-Authors

H-index: 164
Claudiu T. Supuran

Claudiu T. Supuran

Università degli Studi di Firenze

H-index: 65
Louis Maes

Louis Maes

Universiteit Antwerpen

H-index: 55
Fabrizio Manetti

Fabrizio Manetti

Università degli Studi di Siena

H-index: 48
Enzo Tramontano

Enzo Tramontano

Università degli Studi di Cagliari

H-index: 41
Roberto Di Santo

Roberto Di Santo

Sapienza Università di Roma

H-index: 37
Roberta Costi

Roberta Costi

Sapienza Università di Roma

academic-engine